Europe Sclerotherapy Market Size & Outlook, 2025-2030

The sclerotherapy market in Europe is expected to reach a projected revenue of US$ 337.6 million by 2030. A compound annual growth rate of 4.5% is expected of Europe sclerotherapy market from 2025 to 2030.
Revenue, 2024 (US$M)
$256.4
Forecast, 2030 (US$M)
$337.6
CAGR, 2025 - 2030
4.5%
Report Coverage
Europe

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Europe sclerotherapy market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Europe sclerotherapy market highlights

  • The Europe sclerotherapy market generated a revenue of USD 256.4 million in 2024.
  • The market is expected to grow at a CAGR of 4.5% from 2025 to 2030.
  • In terms of segment, detergents was the largest revenue generating agent in 2024.
  • Detergents is the most lucrative agent segment registering the fastest growth during the forecast period.
  • Country-wise, Germany is expected to register the highest CAGR from 2025 to 2030.


Europe data book summary

Market revenue in 2024USD 256.4 million
Market revenue in 2030USD 337.6 million
Growth rate4.5% (CAGR from 2025 to 2030)
Largest segmentDetergents
Fastest growing segmentDetergents
Historical data covered2018 - 2023
Base year for estimation2024
Forecast period covered2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationDetergents, Chemical Irritants, Osmotic Agents
Key market players worldwideB2Gold Corp, LGM Pharma, Troikaa Pharmaceuticals, Mylan, Perrigo Co PLC, Merz Pharma, Medi-Globe


Other key industry trends

  • In terms of revenue, Europe region accounted for 22.4% of the global sclerotherapy market in 2024.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 374.8 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Sclerotherapy Market Companies

Name Profile # Employees HQ Website
Troikaa Pharmaceuticals View profile 1001-5000 Ahmedabad, Gujarat, India, Asia http://www.troikaa.com/
LGM Pharma View profile 101-250 Nashville, Tennessee, United States, North America https://lgmpharma.com/
B2Gold Corp View profile 6150 666 Burrard Street, Park Place, Suite 3400, Vancouver, BC, Canada, V6C 2X8 https://www.b2gold.com
Mylan View profile 10001+ https://www.mylan.in/
Medi-Globe View profile 101-250 Rohrdorf, Bayern, Germany, Europe https://www.medi-globe.de
Perrigo Co PLC View profile 9140 The Sharp Building, Hogan Place, Dublin, Ireland, D02 TY74 https://www.perrigo.com
Merz Pharma View profile 5001-10000 Deutsch, Sachsen, Germany, Europe http://www.merz.com

Europe sclerotherapy market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to sclerotherapy market will help companies and investors design strategic landscapes.


Detergents was the largest segment with a revenue share of 46.26% in 2024. Horizon Databook has segmented the Europe sclerotherapy market based on detergents, chemical irritants, osmotic agents covering the revenue growth of each sub-segment from 2018 to 2030.


Europe was the second largest contributor towards Sclerotherapy market globally after North Americain 2019. The countries in the European region are well developed imparting a significant infrastructure facilities to provide modern technologies relating to venous treatments.

Accessibility to superlative health facilities, experienced practitioners, rising geriatric population and rising incidence of varicose veins among the European population are factors contributing to revenue growth in this region. Drivers like huge patient population, and high demand of minimally invasive procedures is making Europe a key attraction for market players.

Reasons to subscribe to Europe sclerotherapy market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Europe sclerotherapy market databook

  • Our clientele includes a mix of sclerotherapy market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe sclerotherapy market, including forecasts for subscribers. This continent databook contains high-level insights into Europe sclerotherapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Europe sclerotherapy market size, by country, 2018-2030 (US$M)

Europe Sclerotherapy Market Share, 2024 & 2030 (US$M)

Europe sclerotherapy market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online